Search

Your search keyword '"Joseph L. Thomas"' showing total 3 results
Start Over Author "Joseph L. Thomas" Journal jacc: cardiovascular interventions
3 results on '"Joseph L. Thomas"'

1. CRT-800.42 Transcatheter Atrial Septal Defect Occluder Devices: Trends in Adverse Events and Erosions in a Public Database

Author

Priya Pillutla, Shivani Shodhan, Sonia U. Shah, Joshua Lu, and Joseph L. Thomas

Subjects
medicine.medical_specialty, business.industry, Internal medicine, medicine, Cardiology, Cardiology and Cardiovascular Medicine, Adverse effect, business
Abstract

The risk of cardiac erosion with commercially available atrial septal defect occluders has led to changes in device labeling and implantation technique. Previous reports have described publicly-available data on erosion events but have not included recent experience. The FDA Manufacturer and User

Published
2017
Full Text
View/download PDF

2. CRT-711 Publicly Reported Adverse Events with the Edwards SAPIEN Valve - Trends and Event Classification in the FDA MAUDE Database

Author

Joseph L. Thomas, Aram Gabrielyan, Vinoy Prasad, William J. French, Sarkis Kiramijyan, and Nimish Patel

Subjects
Database, Transcatheter aortic, business.industry, Event (computing), medicine.medical_treatment, computer.software_genre, Valve replacement, cardiovascular system, Medicine, cardiovascular diseases, Cardiology and Cardiovascular Medicine, business, Adverse effect, computer, circulatory and respiratory physiology, Edwards sapien
Abstract

The frequency and significance of adverse events (AE) reported with transcatheter aortic valve replacement (TAVR) using Edwards SAPIEN THV in the voluntary, publicly available MAUDE database has not been characterized. The FDA MAUDE Database was queried for all reported events relating to Edwards

Published
2014
Full Text
View/download PDF

3. CRT-101 No Closure on Publicly Reported Adverse Events with Vascular Closure Devices

Author

Joseph L. Thomas, William J. French, Nimesh Patel, and Sarkis Kiramijyan

Subjects
medicine.medical_specialty, surgical procedures, operative, business.industry, medicine, cardiovascular system, Vascular closure device, cardiovascular diseases, Closure (psychology), business, Adverse effect, Cardiology and Cardiovascular Medicine, Surgery
Abstract

The use of vascular closure devices (VCDs) following transfemoral procedures reduces recovery time and may reduce bleeding. Transradial (TR) access is associated with fewer adverse events (AEs). The frequency of real-world AEs with VCDs and the effect of increasing TR access are unknown. The FDA

Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results